Emulating a target trial of statin use and risk of dementia using cohort data
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Observational data can be used to attempt to emulate a target trial of statin use and estimate analogues of intention-to-treat and per protocol effects on dementia risk. METHODS: Using data from a prospective cohort study in the Netherlands, we conceptualized a sequence of "trials" in which eligible individuals ages 55-80 years were classified as statin initiators or noninitiators for every consecutive month between 1993 and 2007 and were followed until diagnosis of dementia, death, loss to follow-up, or the end of follow-up. We estimated 2 types of effects of statin use on dementia and a combined endpoint of dementia or death: the effect of initiation vs no initiation and the effect of sustained use vs no use. We estimated risk by statin treatment strategy over time via pooled logistic regression. We used inverse-probability weighting to account for treatment-confounder feedback in estimation of per-protocol effects. RESULTS: Of 233,526 eligible person-trials (6,373 individuals), there were 622 initiators and 232,904 noninitiators. Comparing statin initiation with no initiation, the 10-year risk differences (95% confidence interval) were -0.1% (-2.3% to 1.8%) for dementia and 0.3% (-2.7% to 3.3%) for dementia or death. Comparing sustained statin use vs no use, the 10-year risk differences were -2.2% (-5.2% to 1.6%) for dementia and -5.1% (-10.5% to -1.1%) for dementia or death. CONCLUSIONS: Individuals with sustained statin use, but not statin initiation alone, had reduced 10-year risks of dementia and dementia or death. Our results should be interpreted with caution due to the small number of initiators and events and potential for residual confounding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Using data from 6373 participants aged 55-80 years an emulated trial found sustained statin use, but not statin initiation alone, to be associated with reduced 10-year risk of dementia or death.(164)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [164]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.
Hernán, M. A., & Robins, J. M. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv254 · Cited by 3,115
Constructing Inverse Probability Weights for Marginal Structural Models
Cole, S. R., & Hernan, M. A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn164 · Cited by 2,796
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,782
Evaluating medication effects outside of clinical trials: new-user designs
Ray, W. A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg231 · Cited by 1,646 · cited 1×
“Finally, methods to estimate the effect of sustained statin treatment over follow-up time in addition to the effect of initiating statin treatment are underutilized in analyses of randomized trials and observational studies alike.(27)”
MethodThe Rotterdam Study: objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,395
Self-citationInstruments for Causal Inference: An Epidemiologist's Dream?
Hernán, M. A., & Robins, J. M. (2006) · Epidemiology · doi:10.1097/01.ede.0000222409.00878.37 · Cited by 961 · cited 1×
“Instrumental variable approaches that do not rely onmeasuring exposure–outcome confounders but instead make different strong assumptions(41) may offer a complementary way to estimate per-protocol effect analogues in some studies, but these methods are not well suited for estimating sustained treatment strategies.(41,4…”
MethodBeyond the intention-to-treat in comparative effectiveness research
Hernán, M. A., & Hernández-Díaz, S. (2012) · Clinical Trials · doi:10.1177/1740774511420743 · Cited by 528 · cited 1×
“Moreover, the effect of sustained medication use may be of great value for informing personal, clinical, or public health decision-making, even though randomized clinical trials often emphasize or solely estimate an intention-to-treat effect regardless of sustained use.(1)”
BackgroundHippisley-Cox, J., & Coupland, C. (2010) · BMJ · doi:10.1136/bmj.c2197 · Cited by 512
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Hansford, H. J., Cashin, A. G., Jones, M. D., Swanson, S. A., Islam, N., Douglas, S. R. G., Rizzo, R. R. N., Devonshire, J. J., Williams, S. A., Dahabreh, I. J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.36023 · Cited by 129
Self-citationKeogh, R. H., Gran, J. M., Seaman, S. R., Davies, G., & Vansteelandt, S. (2023) · Statistics in Medicine · doi:10.1002/sim.9718 · Cited by 65
Caniglia, E. C., Zash, R., Fennell, C., Diseko, M., Mayondi, G. K., Heintz, J. R., Mmalane, M. O., Makhema, J. M., Lockman, S., Mumford, S. L., et al. (2023) · Epidemiology · doi:10.1097/ede.0000000000001601 · Cited by 61
Self-citationChen, Y., Wang, X., Guan, L., & Wang, Y. (2021) · Biomolecules · doi:10.3390/biom11081102 · Cited by 60
Metadata
- Authors
- Caniglia, E. C., Rojas-Saunero, L. P., Hilal, S., Licher, S., Logan, R., Stricker, B., Ikram, M. A., & Swanson, S. A.
- Affiliations
- Harvard University (US)
- From the Department of Population Health (E.C.C.), New York University School of Medicine, New York; Departments of Epidemiology (L.P.R.-S., S.H., S.L., B.S., M.A.I., S.A.S.) and Radiology and Nuclear Medicine (S.H.), Erasmus MC–University Medical Center Rotterdam, the Netherlands; and Department of Epidemiology (E.C.C., R.L., S.A.S.), Harvard T.H. Chan School of Public Health, Boston, MA. S. Hilal is presently at Saw Swee Hock School of Public Health, National University of Singapore.
- Venue
- Neurology
- Published
- 2020-09-08
- Volume
- 95
- Issue
- 10
- Pages
- e1322-e1332
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC7538212
- OpenAlex
- W3047007063
- Cited by
- 56
- References
- 45
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 16 · 2023: 10 · 2022: 4 · 2021: 5
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Funders
- ZonMw (73305095005)
- National Institute of Allergy and Infectious Diseases (R01AI073127, T32AI007433)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- statins, dementia risk, target trial emulation, intention-to-treat effect, statin initiation, inverse probability weighting, dementia mortality, older adults
- MeSH terms
- Aged, Aged, 80 and over, Dementia, Female, Humans, Male, Middle Aged, Incidence, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emulating a target trial of statin use and risk of dementia using cohort data. https://app.cochat.ai/papers/10.1212/wnl.0000000000010433
- The paper
- Caniglia, E. C., Rojas-Saunero, L. P., Hilal, S., Licher, S., Logan, R., Stricker, B., Ikram, M. A., & Swanson, S. A. (2020). Emulating a target trial of statin use and risk of dementia using cohort data. Neurology. https://doi.org/10.1212/wnl.0000000000010433
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.